Introduction
The p53 tumor suppressor protein plays a central role in the cellular response to DNA damage by controlling genes involved in cell cycle arrest and apoptosis (Prives and Hall, 1999; Vogelstein et al., 2000; Vousden and Lu, 2002; Slee et al., 2004; Harris and Levine, 2005) . The mutation of p53 is one of the most common events found in human tumors, including oral SCC (Sakai and Tsuchida, 1992; Olivier et al., 2002) . The restoration of wild-type p53 could be a potential therapeutic approach to human tumors. However, introduction of wild-type p53 causes different responses to tumors, some of which are resistant to p53-mediated apoptosis (Polyak et al., 1996) . Although certain forms of mutant p53 protein expressed in p53-resistant tumors have been shown to interfere the action of wild-type p53, the mechanism underlying the p53 resistance has not been fully understood.
Numerous studies have demonstrated that the activity of p53 protein is modulated by post-transcriptional modifications including the phosphorylation of specific residues in the N-and C-terminal domains (Appella and Anderson, 2001; Bode and Dong, 2004) . Phosphorylation of p53 at specific N-terminal serines, including Ser6, Ser9, Ser15, Ser20 and Ser37, in response to DNA damage contributes to increase the stability and activity of p53 by reducing its ability to bind MDM2, a negative regulator of p53 (Shieh et al., 1997; Siliciano et al., 1997; Pise-Masison et al., 1998; Unger et al., 1999; Kapoor et al., 2000; Bean and Stark, 2001; Dohoney et al., 2004; Restle et al., 2005) . Phosphorylation of Ser46 is induced following DNA-damage and has been shown to be critical for inducing p53-mediated apoptosis, which is associated with transcriptional activation of proapoptotic p53AIP1 gene mediated by p53 (Oda et al., 2000b) . Phosphorylation of Ser46 has been shown to be mediated by p38 mitogen-activated protein (MAP) kinase (Bulavin et al., 1999) and homeodomain-interacting protein kinase-2 (HIPK2) (D'Orazi et al., 2002; Hofmann et al., 2002) . HIPK2 is activated by UV radiation and selectively phosphorylates Ser46 on p53. A recent study demonstrated that HIPK2 inhibits nuclear export and degradation mediated by MDM2, thereby promoting transcriptional activity and apoptotic function of p53 (Di Stefano et al., 2004) . Nevertheless, the precise role of Ser46 phosphorylation relative to the other N-terminus phosphorylation events in disrupting MDM2 interaction remains to be determined.
Overexpression of wild-type p53 using expression vectors, such as those driven by a strong viral promoter, generates large amounts of p53 protein over its physiological levels in a cell. Recent studies have provided evidence that the regulation of the intracellular level of p53 free from MDM2 is the major role for the N-terminal phosphorylation under physiological conditions (Jackson et al., 2004; Thompson et al., 2004; Vassilev et al., 2004) . Inhibition of p53-MDM2 interaction by either p14ARF, a negative regulator of MDM2, or nutlin-3, a MDM2 antagonist, is sufficient to stabilize endogenous wild-type p53, and activate p53-dependent transcription and apoptosis in the absence of the major N-terminal phosphorylation, including Ser46, indicating that the p53 phosphorylation is dispensable for transcriptional activation and apoptosis. Although numerous studies have shown that mutation of specific phosphorylation sites on the N-terminus of p53 reduces the activity of p53, the recent evidence raises the question of whether the N-terminal phosphorylation is essential under conditions where high levels of p53 are expressed. The lack of Ser46 phosphorylation is observed in some tumor cells resistant to p53 gene transfer (Ro¨dicker and Pu¨tzer, 2003; Ohtani et al., 2004) . However, there is no direct evidence supporting the assumption that the inability to phosphorylate Ser46 on exogenous p53 is responsible for the acquisition of resistance to p53 in tumor cells. Herein, we examined the responses of oral SCC cell lines lacking functional p53 to the introduction of wild-type p53, and found p53-resistant cells lacking Ser46 phosphorylation of exogenous p53. Expression of a p53 mutant substituted Ser46 with Asp (S46D)-induced apoptosis and suppressed colony formation in tumor cells lacking Ser46 phosphorylation, indicating the involvement of this phosphorylation defect in the acquisition of p53 resistance in oral SCC cells.
Results

HSC-3 and HSC-4 cells are p53-resistant
To examine the responses of oral SCC cell lines to the introduction of wild-type p53, we chose four cell lines having various forms of mutated p53. HSC-4 and HOC313 cells possess missense mutations generating p53R248Q and p53E285K, respectively, whereas HSC-2 and HSC-3 cells have mutations causing the C-terminal truncation of p53 protein (Sakai and Tsuchida, 1992) . We first examined the sensitivity to p53-mediated apoptosis in oral SCC cell lines, and compared it with that of wild-type p53-expressing A549 cells. Laser scanning cytometry (LSC) revealed that the infection of adenovirus expressing p53 (Ad-p53) at a multiplicity of infection (MOI) of 20 induced apoptosis in HSC-2 cells (sub-G1 ¼ 54%) and A549 cells (sub-G1 ¼ 38%) in this setting. At a higher MOI of 80, p53 induced apoptosis in HOC313 cells (sub-G1 ¼ 69%) but did not cause significant increase of sub-G1 fractions in HSC-3 or HSC-4 cells. To confirm p53-induced apoptosis in oral SCC cells, we used Western blotting to monitor the cleavage of PARP by using a PARP antibody specific for the p85 PARP fragment resulting from caspase cleavage (Chiarugi and Moskowitz, 2002) . In parallel, we also examined induction of proapoptotic Apaf1 protein by Ad-p53. Consistent with the results of LSC analysis, both PARP cleavage and Apaf1 induction following Ad-p53 infection (MOI ¼ 80) were evident in the p53-sensitive HSC-2 and HOC313, but not p53-resistant HSC-3 and HSC-4 cells (Figure 1b) .
To further examine the resistance of HSC-3 and HSC-4 cells to exogenous p53, we performed colony formation assays to determine whether the introduction of p53 suppresses the growth of oral SCC cells. Cells were transfected with plasmids expressing p53wild-type (WT) and the neomycin-resistance gene, and then cultured in the presence of G418 for 3-4 weeks. As for HSC-4 cells, transfection of p53 expression vectors increased their tendency to come off from culture plates. Therefore, to minimize the formation of satellite colonies around the original colonies, we counted the colonies of HSC-4 cells 10 days after transfection. We used an empty vector and the vector expressing the p53C135Y mutant, which lacks growth suppressive activity, as negative controls. Transfection of p53WT did not suppress the growth of HSC-3 and HSC-4 cells, whereas transfection of p53WT resulted in substantial growth suppression of HSC-2 and HOC313 cells (Figure 2a and b) . Furthermore, Western blotting analysis confirmed the expression of transfected p53WT gene in the neomycin-resistant colonies of HSC-3 cells after colony formation (Figure 2c ). Collectively, we conclude that HSC-3 and HSC-4 cells are resistant to the introduction of wild-type p53.
Expression of proapoptotic target genes is not induced by p53 in HSC-3 and HSC-4 cells It has been shown that p53-dependent apoptosis and growth suppression are regulated, at least in part, by the transcriptional activation of its target genes. We next examined the induction of p53 target genes by exogenous p53 in p53-resistant HSC-3 and HSC-4 cells, and compared it with that of p53-sensitive A549, HSC-2, and HOC313 cells by quantitative real-time reverse transcription (RT)-PCR (Figure 3a) . Infection of Adp53 (MOI ¼ 20) induced the expression of all of genes examined in A549 cells. Except for Noxa, the similar results were obtained with HSC-2 cells, whereas Ad-p53 induced only p21
Waf1 and, to a lesser extent, p53DINP1 in HSC-3 cells. None of the proapoptotic target genes examined, such as p53AIP1, Apaf1, PUMA and Noxa, were induced in the p53-resistant HSC-3 and HSC-4 cells. In HOC313 cells, p53DINP1 and, to a lesser extent, PUMA, was upregulated, but the other proapoptotic target genes were not induced by Ad-p53 infection, which is consistent with the fact that HOC313 cells did not undergo apoptosis under these conditions (MOI ¼ 20) (Figure 1 ). In agreement with the above results, Western blotting analysis revealed that expression of p21
Waf1 and PUMA were detected in the p53-sensitive cells following Ad-p53 infection (MOI ¼ 20), whereas only p21 Waf1 was induced in HSC-3 cells and none of these proteins were induced in HSC-4 cells (Figure 3b ).
Phosphorylation of serine 46 is impaired in HSC-3 cells
Western blotting of the above cell lines in the presence or absence of doxorubicin revealed that HSC-4 and HOC313 cells expressed high levels of mutant p53 proteins independent of DNA damage, whereas wildtype p53 expressed in A549 cells was induced upon doxorubicin treatment (Figure 4a ). The resistance of HSC-4 and, to a lesser extent, HOC313 cells to p53-mediated apoptosis is supported by the fact that accumulated p53 proteins carrying single-amino-acid substitutions act as dominant-negative inhibitors of wild-type p53 (Ko and Prives, 1996; de Vries et al., 2002; Vousden and Lu, 2002) . In contrast, the expression of the truncated p53 proteins was barely detectable in HSC-2 and HSC-3 cells (Figure 4a and data not shown).
Since the Ser46 phosphorylation of p53 has been shown to be required for inducing expression of a proapoptotic target gene p53AIP1, but not a critical cell cycle inhibitor, p21
Waf1 (Oda et al., 2000b) , we investigated whether phosphorylation of exogenous p53 proteins is involved in the p53 resistance of HSC-3 cells lacking the accumulation of mutant p53. Western blotting of extracts prepared from cells infected with increasing amounts of Ad-p53 (MOI ¼ 0, 20, and 80) by using phospho-specific p53 antibodies revealed that phosphorylation of exogenous p53 on Ser46 was hardly detected in HSC-3 cells (Figure 4b ). Although Ser15 phosphorylation was not evident in HSC-3 cells at a low dose (MOI ¼ 20), Ad-p53 infection at a high dose (MOI ¼ 80) induced considerable levels of Ser15 in HSC-3 cells. In contrast, the phosphorylation of both Ser15 and Ser46 were clearly detected in the others, including HSC-4 cells. These results indicate that the Ser46 phosphorylation of exogenous p53 is severely impaired in HSC-3 cells.
The phosphorylated form of p53 on Ser46 induced apoptosis and growth suppression in HSC-3 cells The evidence presented above suggests that the defect in Ser46 phosphorylation in HSC-3 cells might account for the lack of induction of proapoptotic p53-target gene expression by p53, thereby leading to the resistance to p53-mediated apoptosis. To address this possibility, we first investigated whether the phosphorylation status of p53 on serine 46 affects the responses of p53-target gene promoters to p53 in HSC-3 cells. We transfected plasmids expressing either wild-type p53 or its mutant S46D (which mimics the phosphorylated p53 on Ser46) into HSC-3 cells, and measured their activities for transactivating the cell-cycle inhibitor p21 waf1 and proapoptotic Noxa promoters using luciferase reporter assay. Consistent with the results of real-time RT-PCR analysis (Figure 3a) , p53WT activated the p21 waf1 but not Noxa promoter in HSC-3 cells (Figure 5a ). Transfection of the S46D mutant induced Noxa promoter activity (2.2 fold) and also showed a higher activity than p53WT against the p21 waf1 promoter. We next examined the effects of Ser46 phosphorylation on p53-mediated apoptosis and growth suppression in HSC-3 cells. To this end, cells were transfected with either the wild-type p53 or p53S46D plasmid, and stained with a-p53 antibody. Figure 5b shows that, compared to p53WT, transfection of the S46D mutant doubled the number of blebbing and shrunken nuclei, which are the characteristics of apoptosis, in p53-positive HSC-3 cells. Furthermore, the growth suppressive activity of p53S46D in HSC-3 is demonstrated by the fact that HSC-3 cells transfected with p53S46D formed half the number of colonies compared to those transfected with p53WT or the empty vector (Figure 5c and d) , indicating that expression of the p53 mutant mimicking Ser46 phosphorylation is able to overcome the resistance to p53-mediated apoptosis and growth suppression in HSC-3 cells lacking Ser46 phosphorylation. Conversely, the importance of Ser46 phosphorylation in p53-mediated growth suppression is also confirmed by the fact that transfection of Ser46-phosphorylation defective p53S46A mutant failed to suppress colony formation of p53-sensitive HSC-2 cells (Figure 5e and f) . Nevertheless, consistent with the fact that HSC-4 cells are able to phosphorylate Ser46 of p53, but yet they are resistant to wild-type p53, the p53S46D mutant had no effect on the growth suppression of HSC-4 cells (Figure 5d , right panel).
Restoration of apoptotic activity of wild-type p53 by inhibition of endogenous mutant p53 in HSC-4 cells The resistance to p53S46D, together with the accumulation of endogenous p53R248Q mutant protein in HSC-4 cells, suggests that a distinct mechanism involving a dominant-negative effect of the mutant protein on wildtype p53 function may contribute to the p53 resistance of HSC-4 cells. To address this possibility, we examined whether reduction of endogenous p53R248Q expression Defect in Ser46-phosphorylation of p53 SJA Ichwan et al can restore p53-mediated apoptosis in HSC-4 cells. It has been shown that a single base difference in the center of siRNAs discriminates between wild-type and R248W mutant p53 in cells expressing both forms, resulting in the restoration of wild-type p53 function (Martinez et al., 2002) . Accordingly, we made use of a siRNA specific for the sequence of p53R248Q (Figure 6a) , and analysed its suppression efficiency on the expression of the endogenous mutant protein in HSC-4 cells. Western blotting analysis revealed that the p53R248Q siRNA strongly inhibited the expression of the mutant protein (Figure 6b ). We next examined whether the mutantspecific siRNA could restore the apoptotic activity of exogenous p53WT in HSC-4 cells. To this end, cells were infected with Ad-p53 following siRNA transfection, and then DNA profiles were analysed by LSC. The transfection of p53R248Q siRNA resulted in a restoration of apoptosis following Ad-p53 infection in HSC-4 cells (sub-G1 ¼ 18%), whereas a control siRNA of irrelevant sequence caused no significant increase of sub-G1 fractions in Ad-p53 infected cells (sub-G1 ¼ 4%), compared to Ad-con infected cells (sub-G1 ¼ 3%) (Figure 6c ). Similar results were obtained when we examined PARP cleavage (Figure 6d, top) . Western blotting with the p85 PARP antibody revealed that Ad-p53 induced PARP cleavage in cells treated with p53R248Q, but not control siRNA. To confirm these results, we examined the specificity of the p53R248Q siRNA in HSC-4 cells by Western blotting (Figure 6d, middle) . The p53R248Q protein migrated 
Defect in Ser46-phosphorylation of p53
SJA Ichwan et al faster than exogenous wild-type p53, which is due to a common polymorphism at codon 72 (Marin et al., 2000) . Direct sequencing of these cDNAs revealed that the R248Q mutant contained an arginine at residue 72 (72R), whereas wild-type p53 used in this study contained a proline at this position (72P) (data not shown). After cotreatment with the p53R248Q siRNA and Ad-p53, there was a clear reduction in the amount of the endogenous mutant protein, whereas exogenous wild-type p53 levels were affected to a much lesser extent. Collectively, these results support the notion that the mutant p53R248Q protein antagonizes the activity of exogenous wild-type p53 in a dominant-negative manner, resulting in the acquisition of p53-resistant in HSC-4 cells. In addition, we observed that the mutantspecific siRNA slightly induced PARP cleavage in cells infected with the control virus (Figure 6d , middle). In this regard, endogenous p53R248Q protein may play a role in the survival of HSC-4 cells by suppressing p73 function, since the 72P polymorphism in the mutant protein enhances the ability of mutant p53 proteins to interact with p73 and interfere its function (Marin et al., 2000; Strano et al., 2000; Bergamaschi et al., 2003) .
Discussion
Results presented in this study demonstrate that Ser46 phosphorylation is critical for p53-mediated apoptosis and tumor growth suppression, and that the defect in its phosphorylation contributes to the acquisition of the p53 resistantance in HSC-3 cells. Many lines of evidence have demonstrated the importance of Ser46 phosphorylation for the apoptotic function of p53 (Bulavin et al., 1999; Oda et al., 2000b; D'Orazi et al., 2002; Hofmann et al., 2002; Mayo et al., 2005) . Specifically, the substitution of this site with Ala reduces the ability of p53 to induce apoptosis. In this study, we examined whether a defect in Ser46 phosphorylation accounts for acquisition of p53 resistance in oral SCC in the presence of high levels of wild-type p53 protein. We show that HSC-3 cells, which lack the ability to phosphorylate Ser46 on p53, impair transcriptional activation of proapoptotic genes and are resistant to apoptosis and growth suppression mediated by exogenous p53. Introduction of the p53S46D mutant can overcome the resistance to p53-mediated apoptosis and growth suppression in HSC-3 cells. Conversely, Ser46-phosphorylation defective p53S46A mutant failed to suppress colony formation of p53-sensitive HSC-2 cells. These results indicate that the inability to phosphorylate Ser46 on p53 is responsible for acquisition of the resistance to p53 gene transfer in oral SCC. In contrast, the p53 resistance of HSC-4 cells, which are able to phosphorylate Ser46 and are resistant to p53S46D, is due to a dominant-negative effect of endogenous p53R248Q protein on wild-type p53 function. Indeed, we show that inhibition of endogenous p53R248Q by siRNA can restore p53 function, resulting in the induction of apoptosis by Ad-53 infection in HSC-4 cells. Results presented here, along with previous observations (Rodicker and Putzer, 2003; Ohtani et al., 2004) , suggest that the defect in Ser46 phosphorylation contributes to the acquisition of p53 resistance in certain populations of human tumors. It has been shown that Ser46 phosphorylation selectively induces transcription proapoptotic p53AIP1 gene (Oda et al., 2000b) . In agreement with this, we show that expression of p21
Waf1
, but not p53AIP1, was induced by exogenous p53 in HSC-3 cells. We also show that exogenous p53 was unable to induce other proapoptotic target genes, such as Apaf1, PUMA and Noxa, and that the Noxa promoter activity was restored by introduction of the S46D mutant in HSC-3 cells, suggesting that the defect in Ser46 phosphorylation affects expression of a number of proapoptotic p53-target genes. While p21 Waf1 is a critical mediator of p53 for cell cycle arrest, the fact that exogenous p53 induced expression of p21
Waf1 but did not suppress colony formation in HSC-3 cells suggests that the ability of p53 to induce p21
Waf1 by itself is not sufficient for complete growth arrest in the stable transfection assay, and that the apoptosis activity of p53 is required for this process.
Phosphorylation of the N-terminal serines on p53 contributes to the stabilization and activation of p53 protein by reducing its ability to bind MDM2, thereby allowing p53 to exhibit its biological functions. However, a previous study has demonstrated that mutation of most of the major phosphorylation sites, including Ser6, Ser9, Ser15, Ser20 and Ser37, results in only subtle changes in MDM2 interaction (Ashcroft et al., 1999) . Considering the importance of Ser46 phosphorylation in the absence of Ser46 phosphorylation, p53 overexpression and its subsequent post-translational modifications, such as Ser15, can increase the p53 level enough to induce p21
Waf1 , and then Ser46 phosphorylation might play a critical role for making p53 more resistant to MDM2, thereby allowing an increase in the p53 level to be sufficient to induce expression of proapoptotic p53-target genes. Indeed, the importance of the intracellular p53 level in its functions is supported by recent studies by using inhibitors of MDM2, demonstrating that separating p53 from MDM2 is sufficient for transcriptional activation and apoptosis (Thompson et al., 2004; Vassilev et al., 2004) . Nevertheless, it still remains unclear why p53 overexpression, which possibly generates an excess of its protein over endogenous MDM2, is unable to overcome the MDM2-mediated inhibition in HSC-3 cells. In this regard, evidence demonstrated by recent studies suggests an alternative possibility that a change of p53 protein conformation caused by Ser46 phosphorylation may affect its target gene specificity (Oda et al., 2000b; Mayo et al., 2005) . For instance, in the view of the fact that mutation of Ser46 on p53 impairs specifically its DNA binding affinity to the p53 binding sequences of p53AIP1 but not those of p21
, we cannot rule out the possibility that the inability to phosphorylate p53 protein on Ser46 precludes HSC-3 cells from changing its conformation that is required for inducing proapoptotic target genes, thereby resulting in the resistance to exogenous p53. Further studies are required to address this issue.
Finally, the dysregulation of exogenous p53 in HCS-3 cells suggests that the upstream regulatory pathway involving kinases, including HIPK2, or cofactors, such as p53DINP1, which regulates p53-dependent apoptosis through Ser46 phosphorylation (Okamura et al., 2001) , is abrogated in HSC-3 cells. Understanding of the mechanism underlying the impaired phosphorylation of exogenous p53 in HSC-3 cells may contribute to the development of therapeutic strategies to treat p53-resistant tumors.
Materials and methods
Cells and recombinant adenoviruses HSC-2, HSC-3, HSC-4, HOC313 (oral SCC) and A549 (nonsmall-cell lung carcinoma obtained from RIKEN Cell Bank, Tsukuba, Japan) cells were cultured at 371C in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS). Ad-p53 (obtained from RIKEN Gene Bank), and control Adx1w1 (Ad-con) viruses were purified and viral titers were determined as described . Cells were seeded 1 day before infection at the indicated MOI in serum-free DMEM containing 20 mM HEPES (pH 7.4) for 1 h at 371C with brief agitation every 15 min. After infection, cells were cultured in DMEM containing 10% FCS.
Cell cycle analysis
Total populations of floating and adherent cells were harvested 72 h after infection, fixed with 75% ethanol, and then stained for DNA content as described previously (Tamamori-Adachi et al., 2003). Cell cycle profiles were analysed using a laser scanning cytometer (LSC101; Olympus) as described (TamamoriAdachi et al., 2003) .
Western blotting
Preparation of whole-cell extracts and Western blotting were performed as described . The following antibodies were used in this study: mouse monoclonal p53 (DO-1), p21 (187), b-tubulin (D-10) (Santa Cruz Biotechnology), b-actin (AC-15) (Sigma-Aldrich) antibodies, and rabbit polyclonal phospho-p53 Ser15 and Ser46 (Cell Signaling Technology), Apaf1 (H-324) (Santa Cruz Biotechnology) PUMA (ab9643) (Abcam), and PARP p85 Fragment (Promega) antibodies.
Transfection and colony formation assay Transfection and colony formation assay were performed as described previously (Suganuma et al., 2002) . For siRNA experiments, cells were transfected with siRNAs (250 pmol) by using Lipofectamine 2000 reagent (Invitrogen).
cDNA synthesis Total RNA was prepared using the TRI Reagent (SigmaAldrich). Complementary DNAs were synthesized from 5 mg of total RNA using the ReverTra Ace reverse transcriptase (TOYOBO) according to the manufacturer's instructions.
Quantitative real-time RT-PCR analysis
Quantitative real-time RT-PCR analysis was performed with hydrolysis (TaqMan) probes or hybridization probes, in a LightCycler instrument (Roche Diagnostics). TaqMan probes and primers used were the following Assay on-Demand Gene expression products (Applied Biosystems): p53DINP1 (Hs00264502), Apaf1 (Hs00559441), PUMA (Hs00248075) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Hs99999905). Hybridization probes and primers for p21 WAF1 , p53AIP1 and Noxa were synthesized and purified by reversephase HPLC (Nihon Gene Research Laboratories) (Supplementary Table 1 ). The donor probe was labeled at the 3 0 end with fluorescein, and the anchor probe was labeled with Red 640 at the 5 0 end and modified at the 3 0 end by phosphorylation to block extension. Quantitative real-time PCR reactions were performed in triplicate using 2 ml of cDNA, 10 ml of Quantitect Probe PCR Kit (Qiagen), and appropriate amounts of probes and primers in a final volume of 20 ml, according to the manufacturer's instructions. Transcripts of GAPDH, as a housekeeping gene, were quantified as endogenous RNA of reference to normalize each sample. Quantification was achieved through a calibration curve obtained by serial 10-fold dilutions of the template DNA and the LightCycler software. Results are expressed as relative values.
Plasmids
The p21 Waf1 reporter plasmid (pWWP-Luc) has been described (el-Deiry et al., 1993) . The human Noxa reporter plasmid was provided by N Tanaka (Oda et al., 2000a) . pCMV-p53WT and pCMV-p53C135Y were obtained from Clontech. The p53S46D and p53S46A mutants were generated using the QuickChange II Site-Derected Mutagenesis Kit (Stratagene) with the oligonucleotides 5 0 -ATGGAT GATTTGATGCTGGACCCGGACGATATTGAACAAT-3 0 and 5 0 -ATTGTTCAATATCGTCCGGGTCCAGCATCAAA TCATCCAT-3 0 for p53S46D, and 5 0 -ATGGATGATTTGA TGCTGGCCCCGGACGATATTGAACAAT-3 0 and 5 0 -AT TGTTCAATATCGTCCGGGGCCAGCATCAAATCATC CAT-3 0 for p53S46A. The construct was confirmed by DNA sequencing.
Luciferase assay
Luciferase assays were performed as described previously (Suganuma et al., 2002) . A Renilla Luciferase reporter plasmid was used as an internal control. Luciferase and Renilla luciferase activities were measured using the dual-luciferase reporter assay system (Promega). Luciferase activity was normalized to Renilla-luciferase activity. The data represent the average of three independent experiments.
Immunofluorescent staining Cells were fixed with 3.7% formaldehyde for 10 min at room temperature and stained with anti-p53 antibody (DO-1) followed by Alexa 488-conjugated secondary antibody and propidium iodide (50 mg/ml, Sigma-Aldrich). Images were acquired using a laser scanning confocal microscope (LSM 510 META, Carl Zeiss).
